Shanghai Fosun Pharmaceutical (group) Co., Ltd. Class ASSE: 600196

"Shanghai Fosun Pharmaceutical (Group) Co., Ltd."Announcement on the Public Disclosure and Review Opinion of the List of Participants for the Reserved Grant under the 2025 A-Share Stock Option Incentive Plan Issued by the Remuneration and Appraisal Committee of the Board of Directors

· Issued by Shanghai Fosun Pharmaceutical (group) Co., Ltd. Class A via Shanghai Stock Exchange

Filed with SSE ·

Announcement on the Public Disclosure and Review Opinion of the List of Participants for the Reserved Grant under the 2025 A-Share Stock Option Incentive Plan Issued by the Remuneration and Appraisal Committee of the Board of Directors

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

6ix hasn’t read this filing yet.

Company analysis

Earlier from Shanghai Fosun Pharmaceutical (group) Co., Ltd. Class A

All Shanghai Fosun Pharmaceutical (group) Co., Ltd. Class A news releases